Consumption of a Leuconostoc holzapfelii-enriched synbiotic beverage alters the composition of the microbiota and microbial extracellular vesicles.


Journal

Experimental & molecular medicine
ISSN: 2092-6413
Titre abrégé: Exp Mol Med
Pays: United States
ID NLM: 9607880

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 02 01 2019
accepted: 12 04 2019
revised: 01 04 2019
entrez: 3 8 2019
pubmed: 3 8 2019
medline: 30 5 2020
Statut: epublish

Résumé

Synbiotics, the combination of probiotics and prebiotics, are known to confer health benefits via intestinal microbiota modulation. However, significant intestinal microbiota alterations can be difficult to determine in intervention studies based on solely bacterial stool metagenomic analysis. Intestinal microbiota constituents secrete 20-200-nm-sized extracellular vesicles (EVs) containing microbial DNA, proteins, and lipids that are distributed throughout the body, providing an alternative target for microbiota metagenomic analysis. Here, we determined the impact of a synbiotic beverage enriched with the kimchi-derived bacterium Leuconostoc holzapfelii (L. holzapfelii) on the intestinal microbiota and local and circulatory microbiota-derived EV composition of healthy Korean adults. We isolated microbial DNA from stool bacteria, stool EVs, and urinary EVs and conducted next-generation sequencing of the 16S rDNA V3-V4 regions before and after synbiotic consumption. The species diversity of circulating urinary EVs was significantly increased after synbiotic consumption, while stool bacterial and EV diversity remained unchanged. Furthermore, we found that while a single genus was decreased among the stool bacteria constituents, stool EVs and urinary EVs showed significant alterations in four and eight genera, respectively. Blood chemistry assays revealed that synbiotic consumption significantly lowered aspartate aminotransferase (AST) serum levels, particularly in subjects with starting levels above the normal range (>40 UI/L). In conclusion, the L. holzapfelii-enriched synbiotic beverage greatly altered serum AST levels and microbial EV composition in urine and stool, while only minor changes were observed in the gut microbiota composition. Based on these findings, we suggest the potential use of microbiota-derived EVs as surrogate markers in future predictive diagnosis studies.

Identifiants

pubmed: 31371728
doi: 10.1038/s12276-019-0288-1
pii: 10.1038/s12276-019-0288-1
pmc: PMC6802649
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Subventions

Organisme : National Research Foundation of Korea (NRF)
ID : NRF-2016M3A9B6901516
Pays : International
Organisme : National Research Foundation of Korea (NRF)
ID : NRF-2017M3A9F3047497
Pays : International

Références

Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).
pubmed: 27541692 pmcid: 4991899 doi: 10.1371/journal.pbio.1002533
Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392–400 (2018).
pubmed: 29634682 pmcid: 7043356 doi: 10.1038/nm.4517
Flint, H. J., Scott, K. P., Louis, P. & Duncan, S. H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577–589 (2012).
pubmed: 22945443 doi: 10.1038/nrgastro.2012.156
Ritchie, M. L. & Romanuk, T. N. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS ONE 7, e34938 (2012).
pubmed: 22529959 pmcid: 3329544 doi: 10.1371/journal.pone.0034938
de Oliveira, G. L. V., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I. & Mariano, V. S. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology 152, 1–12 (2017).
pubmed: 28556916 pmcid: 5543467 doi: 10.1111/imm.12765
Pandey, K. R., Naik, S. R. & Vakil, B. V. Probiotics, prebiotics and synbiotics-a review. J. Food Sci. Technol. 52, 7577–7587 (2015).
pubmed: 26604335 pmcid: 4648921 doi: 10.1007/s13197-015-1921-1
Scott, A. J., Merrifield, C. A., Younes, J. A. & Pekelharing, E. P. Pre-, pro- and synbiotics in cancer prevention and treatment—a review of basic and clinical research. Ecancermedicalscience 12, 869 (2018).
pubmed: 30263060 pmcid: 6145522 doi: 10.3332/ecancer.2018.869
Park, B. et al. Identification of 2-hydroxyisocaproic acid production in lactic acid bacteria and evaluation of microbial dynamics during kimchi ripening. Sci. Rep. 7, 10904 (2017).
pubmed: 28883404 pmcid: 5589888 doi: 10.1038/s41598-017-10948-0
Weinberg, Z. G., Muck, R. E., Weimer, P. J., Chen, Y. & Gamburg, M. Lactic acid bacteria used in inoculants for silage as probiotics for ruminants. Appl. Biochem. Biotechnol. 118, 1–7 (2004).
pubmed: 15304734 doi: 10.1385/ABAB:118:1-3:001
Kang, M. S., Kang, I. C., Kim, S. M., Lee, H. C. & Oh, J. S. Effect of Leuconostoc spp. on the formation of Streptococcus mutans biofilm. J. Microbiol. 45, 291–296 (2007).
pubmed: 17846581
Jeong, S. H., Lee, S. H., Jung, J. Y., Choi, E. J. & Jeon, C. O. Microbial succession and metabolite changes during long‐term storage of kimchi. J. Food Sci. 78, M763–M769 (2013).
pubmed: 23550842 doi: 10.1111/1750-3841.12095
Rycroft, C. E., Jones, M. R., Gibson, G. R. & Rastall, R. A. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J. Appl. Microbiol. 91, 878–887 (2001).
pubmed: 11722666 doi: 10.1046/j.1365-2672.2001.01446.x
Paturi, G. et al. Cecal and colonic responses in rats fed 5 or 30% corn oil diets containing either 7.5% broccoli dietary fiber or microcrystalline cellulose. J. Agric. Food Chem. 58, 6510–6515 (2010).
pubmed: 20405907 doi: 10.1021/jf100296m
Grajek, W., Olejnik, A. & Sip, A. Probiotics, prebiotics and antioxidants as functional foods: a review. Acta Biochim. Pol. 52, 665–671 (2005).
pubmed: 16086074 doi: 10.18388/abp.2005_3428
Budak, N. H., Aykin, E., Seydim, A. C., Greene, A. K. & Seydim, Z. B. G. Functional properties of vinegar. J. Food Sci. 79, 757–764 (2014).
doi: 10.1111/1750-3841.12434
Takahashi, R. et al. Antioxidant activities of black and yellow soybeans against low density lipoprotein oxidation. J. Agric. Food Chem. 53, 4578–4582 (2005).
pubmed: 15913328 doi: 10.1021/jf048062m
Li-Shuang, L. V. et al. Stilbene glycosides from the roots of Polygonum multiflorum Thunb and their in vitro antioxidant activities. J. Food Lipids 13, 131–144 (2006).
doi: 10.1111/j.1745-4522.2006.00039.x
Cardona, F. et al. Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 24, 1415–1422 (2013).
pubmed: 23849454 doi: 10.1016/j.jnutbio.2013.05.001
Kang, C. S. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8, e76520 (2013).
pubmed: 24204633 pmcid: 3811976 doi: 10.1371/journal.pone.0076520
Muraca, M., Putignani, L., Fierabracci, A., Teti, A. & Perilongo, G. Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease. Disco. Med. 19, 343–348 (2015).
Kim, J. H., Lee, J., Park, J. & Gho, Y. S. Gram-negative and gram-positive bacterial extracellular vesicles. Semin. Cell Dev. Biol. 40, 97–104 (2015).
pubmed: 25704309 doi: 10.1016/j.semcdb.2015.02.006
Ong, J. P., Pitts, A. & Younossi, Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J. Hepatol. 49, 608–612 (2008).
pubmed: 18682312 doi: 10.1016/j.jhep.2008.06.018
Wen, C. P. et al. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J. Natl Cancer Inst. 104, 1599–1611 (2012).
pubmed: 23073549 pmcid: 3692381 doi: 10.1093/jnci/djs372
Hyeon, C. K. et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 328, 983 (2004).
doi: 10.1136/bmj.38050.593634.63
Prati, D. et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137, 1–10 (2002).
pubmed: 12093239 doi: 10.7326/0003-4819-137-1-200207020-00006
Nabavi, S., Rafraf, M., Somi, M. H., Homayouni-Rad, A. & Asghari-Jafarabadi, M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J. Dairy Sci. 97, 7386–7393 (2014).
pubmed: 25306266 doi: 10.3168/jds.2014-8500
Aller, R. et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur. Rev. Med. Pharm. Sci. 15, 1090–1095 (2011).
Khalesi, S. et al. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis. Eur. J. Nutr. 57, 2037–2053 (2018).
pubmed: 29119235 doi: 10.1007/s00394-017-1568-y
Esposito, E. et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J. Nutr. 139, 905–911 (2009).
pubmed: 19321579 doi: 10.3945/jn.108.101808
Lavekar, A. S. et al. Role of probiotics in the treatment of nonalcoholic fatty liver disease: a meta-analysis. Eur. J. Hepatogastroenterol. 7, 130–137 (2017).
Buss, C. et al. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. Ann. Hepatol. 13, 482–488 (2015).
doi: 10.1016/S1665-2681(19)31246-3
Meng, X. et al. Gut microbiota’s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics. Nutrients 10, E1457 (2018).
pubmed: 30297615 doi: 10.3390/nu10101457
Sybesma, W., Starrenburg, M., Tijsseling, L., Hoefnagel, M. H. N. & Hugenholtz, J. Effects of cultivation conditions on folate production by lactic acid bacteria. Appl. Environ. Microbiol. 69, 4542–4548 (2003).
pubmed: 12902240 pmcid: 169137 doi: 10.1128/AEM.69.8.4542-4548.2003
Halsted, C. H. et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc. Natl Acad. Sci. USA 99, 10072–10077 (2002).
pubmed: 12122204 doi: 10.1073/pnas.112336399 pmcid: 126626
Asgarshirazi, M., Shariat, M. & Sheikh, M. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial. Hepatobiliary Pancreat. Dis. Int. 16, 296–302 (2017).
pubmed: 28603098 doi: 10.1016/S1499-3872(16)60142-X
Haytowitz, D. et al. USDA National Nutrient Database for Standard Reference, Legacy (USDA Agricultural Research Service, Washington DC, USA, 2018) https://www.ars.usda.gov/research/publications/publication/?seqNo115=349687 .
Shin, N. R., Whon, T. W. & Bae, J. W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33, 496–503 (2015).
pubmed: 26210164 doi: 10.1016/j.tibtech.2015.06.011
Choi, Y. W. et al. Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle. Sci. Rep. 5, 15878 (2015).
pubmed: 26510393 pmcid: 4625370 doi: 10.1038/srep15878
Magrone, T. & Emilio, J. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr. Pharm. Des. 19, 1329–1342 (2013).
pubmed: 23151182
Cani, P. D. & Willem, M. V. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8, 1765 (2017).
pubmed: 29018410 pmcid: 5614963 doi: 10.3389/fmicb.2017.01765
Schneeberger, M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5, 16643 (2015).
pubmed: 26563823 pmcid: 4643218 doi: 10.1038/srep16643
Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593–621 (2007).
pubmed: 17934076 pmcid: 2176045 doi: 10.1128/CMR.00008-07
Nadal, I. et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int. J. Obes. 33, 758–767 (2009).
doi: 10.1038/ijo.2008.260
Park, D. Y. et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS ONE 8, e59470 (2013).
pubmed: 23555678 pmcid: 3605452 doi: 10.1371/journal.pone.0059470
Park, S. et al. Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl. Microbiol. Biotechnol. 101, 1605–1614 (2017).
pubmed: 27858139 doi: 10.1007/s00253-016-7953-2
Shen, Y. et al. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12, 509–520 (2012).
pubmed: 22999859 pmcid: 3895402 doi: 10.1016/j.chom.2012.08.004
Bitto, N. J. et al. Bacterial membrane vesicles transport their DNA cargo into host cells. Sci. Rep. 7, 7072 (2017).
pubmed: 28765539 pmcid: 5539193 doi: 10.1038/s41598-017-07288-4
Bayles, K. W. Bacterial programmed cell death: making sense of a paradox. Nat. Rev. Microbiol. 12, 63 (2014).
pubmed: 24336185 pmcid: 4422510 doi: 10.1038/nrmicro3136
Caruso, S. & Poon, I. K. Apoptotic cell-derived extracellular vesicles: more than just debris. Front. Immunol. 9, 1486 (2018).
pubmed: 30002658 pmcid: 6031707 doi: 10.3389/fimmu.2018.01486

Auteurs

Jinho Yang (J)

MD Healthcare Inc., Seoul, Republic of Korea.
Department of Health and Safety Convergence Science, Korea University, Seoul, Republic of Korea.

Andrea McDowell (A)

MD Healthcare Inc., Seoul, Republic of Korea.

Eun Kyoung Kim (EK)

MD Healthcare Inc., Seoul, Republic of Korea.

Hochan Seo (H)

MD Healthcare Inc., Seoul, Republic of Korea.

Kyujin Yum (K)

Coenbio Co., LTD, Seoul, Republic of Korea.

Won Hee Lee (WH)

MD Healthcare Inc., Seoul, Republic of Korea.

Young-Koo Jee (YK)

Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea. ykjee@dankook.ac.kr.

Yoon-Keun Kim (YK)

MD Healthcare Inc., Seoul, Republic of Korea. ykkim@mdhc.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH